HKPD · Cellyan Biotechnology Co., Ltd
AI read · Good for HKPD
The AI's read
This removes an open problem with HKPD’s Nasdaq listing. The earlier 30-business-day stretch below $1 shows its shares had fallen under the required price before recovering. The news helps its listing standing but says nothing about its business results.